Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases,...

Real-world analysis findings highlight overall survival benefit in adolescent and young adult (AYA) newly-diagnosed acute lymphoblastic leukemia (ALL) patients treated with pediatric-inspired...

Premium Cannabis Product Brand Recognized in Four Categories in Arizona's Largest Cannabis Awards Program PHOENIX, Nov. 3, 2022 /PRNewswire/ -- Item 9 Labs—the award-winning, premium cannabis...

Under the Patronage of His Excellency the Minister of Health, we are pleased to announce the 5th Saudi Health Simulation Conference. It will be held November 6-10, 2022 at the Crowne Plaza Hotel &...

KeifeRx, LLC, an emerging clinical-stage biopharmaceutical company specializing in the discovery and development of new treatment options for neurodegenerative and immune diseases, announced today...

Credit Suisse 31st Annual Healthcare Conference 2022: November 8th, 8:35amPT/11:35amET, in Rancho Palos Verdes, CA 13th Annual Jefferies Global Healthcare Conference 2022: November 16th, 8:35amGMT, in

Precision for Medicine, the first biomarker-driven clinical research organization (CRO) supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more...

A multi-site study confirms the use of undiluted EDTA blood for the SeptiCyte RAPID sepsis assay SEATTLE and BRISBANE, Australia, Nov. 3, 2022 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular...

ImmunoGenesis, a clinical-stage biotechnology company developing science-driven immune therapies, today announced that two poster presentations on its lead development program, IMGS-001, will be...

Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in...